Conflict of interest declaration: Mariane de Montalembert

Roles in: Cystic Fibrosis and Genetic Disorders Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
Yes - Novartis company for attending the ASH meeting 2016

b) Fees for speaking?
Yes - Meeting in Cairo , Feb 11-12 2016, from Novartis Hamburg June 20, 2016 from Addmedica Moissac, November 17, 2016 from Addmedica

c) Fees for organising education?
No

d) Funds for research?
Yes - 28 000 euros from Novartis for the GROP association

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
No